Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) Sees Large Growth in Short Interest

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) was the recipient of a significant growth in short interest during the month of May. As of May 15th, there was short interest totaling 134,469 shares, a growth of 27,740.4% from the April 30th total of 483 shares. Currently, 1.2% of the company’s stock are sold short. Based on an average trading volume of 525,489 shares, the days-to-cover ratio is presently 0.3 days.

Hong Kong Pharma Digital Technology Trading Up 0.4%

NASDAQ HKPD traded up $0.00 during trading on Wednesday, reaching $0.54. The company’s stock had a trading volume of 19,192 shares, compared to its average volume of 98,047. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.93 and a quick ratio of 2.73. The business has a 50-day moving average price of $0.61 and a 200-day moving average price of $0.75. Hong Kong Pharma Digital Technology has a 1-year low of $0.37 and a 1-year high of $2.76.

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) last posted its earnings results on Wednesday, March 18th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $3.57 million during the quarter.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Hong Kong Pharma Digital Technology in a research note on Friday, May 1st. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has a consensus rating of “Sell”.

Institutional Trading of Hong Kong Pharma Digital Technology

A hedge fund recently bought a new stake in Hong Kong Pharma Digital Technology stock. StoneX Group Inc. acquired a new position in Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 43,284 shares of the company’s stock, valued at approximately $36,000. StoneX Group Inc. owned about 0.39% of Hong Kong Pharma Digital Technology at the end of the most recent quarter.

About Hong Kong Pharma Digital Technology

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.